Nintedanib NEW
| Price | $60 |
| Package | 1kg |
| Min. Order: | 1kg |
| Supply Ability: | 1000 |
| Update Time: | 2024-09-10 |
Product Details
| Product Name: Nintedanib | CAS No.: 656247-17-5 |
| Min. Order: 1kg | Purity: 99% |
| Supply Ability: 1000 | Release date: 2024/09/10 |
| Nintedanib Chemical Properties |
| Melting point | >237oC (dec.) |
| Boiling point | 742.2±60.0 °C(Predicted) |
| density | 1.284±0.06 g/cm3(Predicted) |
| storage temp. | Refrigerator |
| solubility | DMSO (Slightly), Methanol (Slightly) |
| pka | 11.06±0.20(Predicted) |
| form | Yellow solid. |
| color | Light Yellow to Light Green |
| InChIKey | XZXHXSATPCNXJR-ZIADKAODSA-N |
| SMILES | C(/C1C=CC=CC=1)(=C1\C(NC2=CC(C(=O)OC)=CC=C\12)=O)\NC1C=CC(N(C)C(=O)CN2CCN(C)CC2)=CC=1 |
| Nintedanib Usage And Synthesis |
| Description | Nintedanib is an oral administrated triple tyrosine kinase inhibitors developed by Boehringer Ingelheim, Germany. Its targets include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and basic fiber (BFGF), being able to also inhibit the activation of MAPK and Akt. At present, it is mainly used for cancer treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. The study regarding to the respiratory diseases mainly focuses on the clinical treatment of advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF). In June 2014, Boehringer Ingelheim has announced that the marketing authorization application of Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF) had been confirmed by the European Medicines Agency (EMA) and been included in the accelerated approval list by the EMA. |
Packing &shipping&Payment
Packing:25kg/drum
Shipping:by sea or by air
Payment:T/T,western union,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :
Shipping:by sea or by air
Payment:T/T,western union,moneygram
Packaging Details drum
Port:Tianjin
Lead Time :
| Quantity(Kilograms) | 1 - 10000 | >10000 |
| Est. Time(days) | 5 | To be negotiated |
Company Profile Introduction
Hebei Hongtan Technology Co., Ltd. was established in 2018. In 2019, the Ministry of Foreign Trade was established. The team has 10 members and has invested $300,000 in product development. Our goal is to make everyone can use inexpensive beauty products, the company's products have passed the CE certification, the main products are slimming peptide, anti-wrinkle peptide, melanin peptide, etc., reliable quality, inexpensive.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1KG |
VIP1Y
|
Hangzhou Hyper Chemicals Limited
|
2024-04-11 | |
| $0.00/1kg |
VIP1Y
|
Nanjing Fred Technology Co., Ltd
|
2023-12-19 | |
| $0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-11-23 | |
| $0.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-10-09 | |
| $0.00/1g |
VIP2Y
|
shandong perfect biotechnology co.ltd
|
2023-08-14 | |
| $0.00/1kg |
VIP2Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-07-17 | |
| $0.00/1kg |
VIP2Y
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2022-11-07 | |
| $0.00/1kg |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-22 | |
| $450.00/1kg |
Hebei Linwo New Material Technology Co., LTD
|
2022-07-05 | ||
| $100.00/1Kg/Bag |
Hong Kong Tiansheng New Material Trading Co., Ltd
|
2021-09-15 |
China- Since: 2021-09-01
- Address: Room 1306, Unit 04, Building 1, Tatan International Trade City, 118 Shengli South Street, Qiaoxi Dis
INQUIRY
+86-17731935328
sales03@chemcn.cn